semaglutide and eye disease NAION Network Study Announcement Ozempic and Wegovy Side Effects

Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January 2026

Methylglyoxal is a highly reactive glycating agent produced as a by-product of glycolysis, and excess exposure can induce apoptosis in pancreatic -cells

Improper nutrition can lead to a range of problems, including hair loss, skin issues, blood level abnormalities, and even organ dysfunction

Because the formula contains a significant dose of Omega-3 fatty acids (which have mild blood-thinning properties) and Vitamin E, individuals taking prescription anticoagulants (like warfarin) or antiplatelet medications should consult their physician, as the combination may increase the risk of bleeding